c-Abl activates p38 MAPK independently o
✍
Eva M. Galan-Moya; Javier Hernandez-Losa; Clara I. Aceves Luquero; Miguel A. de
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
French
⚖ 631 KB
## Abstract Activation of p38 MAPK is a critical requisite for the therapeutics activity of the antitumor agent cisplatin. In this sense, a growing body of evidences supports the role of c‐Abl as a major determinant of p38 MAPK activation, especially in response to genotoxic stress when triggered b